Navigation Links
Researchers Discover All-Natural Weapon In The War Against Ovarian Cancer
Date:8/2/2012

BLAUVELT, N.Y., Aug. 2, 2012 /PRNewswire-iReach/ -- A study published in the International Journal of Gynecological Cancer shows that fermented wheat germ extract (FWGE) is effective in killing a wide range of ovarian cancer cells while simultaneously enhancing the cancer-fighting qualities of certain chemotherapy treatments. Previous human clinical studies with FWGE have shown it can significantly improve survival in melanoma, colorectal and oral cancer patients and lessen the side effects of chemotherapy in pediatric cancer patients.

Lead author of the study is Patricia Judson, MD, gynecologic oncologist and researcher at Moffitt Cancer Center in Tampa, Florida's only National Cancer Institute-designated comprehensive cancer center. Having published more than 40 research articles that have examined standards of cancer treatments including radiation and chemotherapy, Judson says she is most excited about the promise fermented wheat germ extract has shown.

"The results of this study greatly exceeded my expectations," said Dr. Judson. "We have proven that Avemar (FWGE) has the ability to kill cancer cells in the petri dish, and that it enhances the effectiveness of chemotherapy treatments." Judson expressed gratitude to the Moffitt Cancer Center Merit Society for funding this study, and said she is actively seeking grants to underwrite the next stage in Avemar research, which will be ovarian cancer trials in animals and ultimately humans.

The study, which had 13 contributors, reinforces and expands upon prior published research that has shown the potential of fermented wheat germ extract as a non-toxic, cancer-fighting agent. According to the study, the team's findings "confirm the value of Avemar - fermented wheat germ extract (FWGE) - as a natural product with anticancer properties that also enhances the activity of existing therapeutic agents. Furthermore, our findings provide substantial insights into the molecular basis of FWGE's effect on human cancer cells."

FWGE was invented by Hungarian biochemist Mate Hidvegi, Ph.D., and has been the subject of more than 100 international experiments on three continents, and more than 30 peer-reviewed articles. Since inventing this all-natural nutraceutical in the early 1990s, Hidvegi has worked to advance the therapeutic potential for patients diagnosed with a variety of cancers. Previous human clinical studies with Avemar have shown it can significantly improve survival in melanoma, colorectal and oral cancer patients and can lessen the side effects of chemotherapy in pediatric cancer patients.

The patented product is manufactured by American BioSciences, Blauvelt, NY. Further research and drug development on fermented wheat germ extract is sponsored by MSC BioTarget, a New York-based biotech firm. If you are interested in interviewing the principals and learning more about this research, please contact Rick Jahnke, MSC BioTarget LLC, ph: 201-788-4963, email: rjahnkemscbio@gmail.com

CONTACT: Rick Jahnke, MSC BioTarget LLC
Email: rjahnkemscbio@gmail.com
Phone: (201) 788-4963

Media Contact: Rick Jahnke MSC BioTarget LLC, 201-788-4963, rjahnkemscbio@gmail.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE MSC BioTarget LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Researchers Developing New Multiple Sclerosis Drug That Can Be Taken Orally
2. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
3. Researchers Evaluate Computer-based Treatment for People with Schizophrenia
4. Van Andel Institute Researchers Find Potential Drug Target For Aggressive Form Of Lymphoma
5. Rethinking Research Ethics: Carnegie Mellon and McGill Researchers Challenge Post-marketing Trial Practices
6. Omeros Announces Discovery in MASP-2 Program
7. Astellas and Fujita Health University Discover Neuronal Maturation Deficits in Patients Suffering from Schizophrenia and Bipolar Disorder
8. Discovery Labs Receives US Patent for Method to Promote Mucus Clearance with Pulmonary Surfactant
9. Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development
10. Global Information, Inc. Announces New Market Forecasts For Drug Discovery Industry as it Emerges from Recession
11. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... EXTON, Pa. , Oct. 12, 2017 ... global leader in innovative solutions for injectable drug administration, ... results before the market opens on Thursday, October 26, ... discuss the results and business expectations at 9:00 a.m. ... 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is ...
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance in ... medical-grade battery-powered display stand specifically designed for endoscopy environments. An innovative ... into a clinical solution to support the improvement of patient outcomes, ... Design ... Solution ...
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease ... end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the end ... mandated by certain health insurance regulations. ... The best time to get a flu shot is by the end ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... As health professionals work to improve their approach to healthcare, there ... more than filling out a survey; in many cases health professionals and patients are ... care and research on the importance of active engagement with patients and members of ...
(Date:10/13/2017)... ... 13, 2017 , ... PurhealthRX , a leading Health and Nutrition Company, ... Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market by ... be easily incorporated into liquid products, while reducing costs to end users. , The ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
Breaking Medicine News(10 mins):